Literature DB >> 9508220

Anthrax as a potential biological warfare agent.

J C Pile1, J D Malone, E M Eitzen, A M Friedlander.   

Abstract

Anthrax is a zoonotic illness recognized since antiquity. Today, human anthrax has been all but eradicated from the industrialized world, with the vast majority of practitioners in the United States unlikely to have seen a case. Unfortunately, the disease remains endemic in many areas of the world, and anthrax poses a threat as a mass casualty-producing weapon if used in a biological warfare capacity.

Entities:  

Mesh:

Year:  1998        PMID: 9508220     DOI: 10.1001/archinte.158.5.429

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  48 in total

1.  In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

Authors:  C H Choe; S S Bouhaouala; I Brook; T B Elliot; G B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Hospital preparedness for victims of chemical or biological terrorism.

Authors:  D C Wetter; W E Daniell; C D Treser
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

3.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

4.  Anthrax: of bison and bioterrorism.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

Review 5.  Recognizing the real threat of biological terror.

Authors:  Richard P Wenzel
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 6.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

7.  Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.

Authors:  Ron Brookmeyer; Elizabeth Johnson; Robert Bollinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-30       Impact factor: 11.205

8.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

9.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

10.  Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.

Authors:  Paul G Ambrose; Alan Forrest; William A Craig; Chistopher M Rubino; Sujata M Bhavnani; George L Drusano; Henry S Heine
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.